October 13, 2022 <\/p>\n
Scientists at the University of Oxford have carried out a study to investigate whether and how peoples genes influence how strong an immune response they mount after vaccination with either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccine.<\/p>\n
The study has been published in Nature Medicine.<\/p>\n
The scientists analysed DNA samples from 1,190 participants whod enrolled in the University of Oxfords COVID-19 vaccine clinical trials, as well as from 1,677 adults who had enrolled on the Com-COV research programme, and from children who had participated in clinical trials for the Oxford-AstraZeneca vaccine.<\/p>\n
Journalists dialled in to this briefing to hear from the scientists who did the study discuss aspects such as:<\/p>\n
which genes in people determine how well their immune system responds to Covid vaccination?<\/p>\n
which bits of the immune system seem to respond differently with different versions of these genes?<\/p>\n
are there certain populations that tend to have specific versions of these genes?<\/p>\n
what is the normal role of these genes?<\/p>\n
are there implications?<\/p>\n<\/p>\n
Speakers included:<\/p>\n
Prof Julian Knight, Professor of Genomic Medicine, Wellcome Centre for Human Genetics, University of Oxford<\/p>\n
Dr Alexander Mentzer, Group Leader at the Wellcome Centre for Human Genetics, University of Oxford, and an Infectious Disease doctor<\/p>\n
Dr Daniel OConnor, University Research Lecturer and Senior Bioinformatician, Oxford Vaccine Group, University of Oxford<\/p>\n<\/p>\n
This Briefing was accompanied by an SMC Roundup of comments.<\/p>\n
<\/p>\n
Read more from the original source:<\/p>\n
Study looking at human genetics and Covid vaccine immune responses - Science Media Centre<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" October 13, 2022 Scientists at the University of Oxford have carried out a study to investigate whether and how peoples genes influence how strong an immune response they mount after vaccination with either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccine. The study has been published in Nature Medicine. The scientists analysed DNA samples from 1,190 participants whod enrolled in the University of Oxfords COVID-19 vaccine clinical trials, as well as from 1,677 adults who had enrolled on the Com-COV research programme, and from children who had participated in clinical trials for the Oxford-AstraZeneca vaccine. Continue reading